Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 20, 2014
Pharmacy Choice - Pharmacy News - August 20, 2014

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
8/20/14 - Biogen Idec: FDA Approves Plegridy for the Treatment of Multiple Sclerosis [Health & Beauty Close - Up]
Biogen Idec on August 15 reported that the U.S. Food and Drug Administration has approved Plegridy, a treatment for people with relapsing forms of multiple sclerosis. "Plegridy offers people with MS robust efficacy, a safety profile consistent with the established interferon class, and significantly fewer injections than other beta interferon trea
8/20/14 - FDA Approves Gmate Smart Meter and App [Health & Beauty Close - Up]
Philosys reported that it has received U.S. Food and Drug Administration 510 K approval for the Gmate Smart Blood Glucose Monitoring System. Philosys said in a release that the Gmate Smart meter is the size of a quarter and connects to the headphone jack on the iPhone, iPod touch or iPad, while using the free Gmate Smart app to deliver blood glucos
8/19/14 - Eli Lilly: FDA Grants Tentative Approval For Insulin Drug Basaglar
INDIANAPOLIS- Eli Lilly and Co said Monday the U.S. Food and Drug Administration granted tentative approval for Basaglar, which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes. Basaglar is Eli Lilly and Boehringer Ingelheim's basal
8/19/14 - FDA Approves Genzymeâ??s Cerdelgaâ?¢ (eliglustat) Capsules
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration has approved Cerdelgaâ?¢ capsules, the only first-line oral therapy for certain adult Gaucher disease type 1 patients. â??Cerdelga is an important new option for people living with Gaucher disease type 1,â?? said Rhonda Buyers, CEO of the National Gaucher Foundati
8/19/14 - FDA approves new drug for rare genetic disease
Cerdelga is from Genzyme, the specialty drugmaker that introduced the first drug for Gaucher's disease 20 years ago. The oral treatment could serve as an alternative to Genzyme's best-selling drug Cerezyme, which is given intravenously. Genzyme says it will soon release pricing for its new drug.
8/19/14 - FDA Approves New Drug to Treat a form of Gaucher Disease
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:. The U.S. Food and Drug Administration today approved Cerdelga for the long-term treatment of adult patients with the Type 1 form of Gaucher disease, a rare genetic disorder. "Today's approval offers another important treatment option

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Lupus: What You Need to Know
This lesson is supported by:
RxSchool
West Virginia Best Practice Prescribing & Drug Diversion Training
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415